Catalyst Wire Dossier Catalyst Wire Dossier

clarithromycin-containing bismuth quadruple therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for clarithromycin-containing bismuth quadruple therapy, covering 2019-09-24 to 2019-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients [Phase 4]

See pricing